Further to its letter dated February 06, 2026, intimating about the date of the Board of Directors Meeting to, consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter and nine months ended December 31, 2025. Eris Lifesciences has informed that pursuant to Regulation 30 and other applicable regulations, if any, of the SEBI (LODR) Regulations, 2015, the Company will hold a conference call for analysts and investors on Friday, February 13, 2026, at 05:30 pm IST. The details of the said call are attached and are also available on Company’s website.
The above information is a part of company’s filings submitted to BSE.
